Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types

Exclusion Criteria

• •Potential subjects who meet any of the following criteria will be excluded from participating in the study:
• •1. Currently pregnant or breast-feeding.
• •2. Diabetes
• •3. Any ocular or systemic allergies or disease which may interfere with contact lens wear (at the discretion of the investigator).
• •4. Any systemic disease, autoimmune disease, or use of medication which may interfere with contact lens wear (at the discretion of the investigator).
• •5. Any infectious diseases (e.g. hepatitis, tuberculosis) or a contagious immunosuppressive disease (eg, HIV), by self-report.
• •6. Current habitual use of Restasis, Xiidra, ocular steroids, or any medication (RX or OTC) that may interfere with contact lens wear (at the discretion of the investigator).
• •7. Grade 2 or greater corneal staining or conjunctival injection on the FDA scale.
• •8. Clinically significant (Grade 3 or greater on the FDA scale) corneal edema, corneal vascularization, or any other abnormalities of the cornea (excluding corneal staining) which would contraindicate contact lens wear.
• •9. Clinically significant (Grade 3 or greater on the FDA scale) tarsal abnormalities which might interfere with contact lens wear.
• •10. Any active ocular abnormalities/conditions that may interfere with contact lens wear (at the discretion of the investigator).
• •11. Any corneal distortion due to previous rigid gas permeable lens wear, surgery or pathology.
• •12. History of any ocular or corneal surgery (eg, RK, PRK, LASIK).
• •13. Habitual contact lens wear modality as extended wear.
• •14. Participation in any pharmaceutical or medical device related clinical trial within 7 days prior to study enrollment.
• •15. History of binocular vision abnormality or strabismus.
• •16. Habitual wearers of rigid gas permeable lens within the past 3 months.
• •17. Employees of investigational clinic (investigator, coordinator, and technician etc.) or family members of employees of the investigational clinic by self-report